Sponsor:
Children's Oncology Group
Code:
NCT02981628
Conditions
Recurrent B Acute Lymphoblastic Leukemia
Recurrent B Lymphoblastic Lymphoma
Refractory B Acute Lymphoblastic Leukemia
Refractory B Lymphoblastic Lymphoma
Eligibility Criteria
Sex: All
Age: 1 - 21
Healthy Volunteers: Not accepted
Interventions
Asparaginase Erwinia chrysanthemi
Biospecimen Collection
Bone Marrow Aspiration and Biopsy
Calaspargase Pegol
Cyclophosphamide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-05-23.